Actively Recruiting
Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne
Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-03-15
46
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the clinical efficacy, safety and tolerability of a photodynamic therapy(PDT) based on a new photosensitizer, Chlorin-e6, in the treatment of moderate to severe acne. The hypothesis is that the therapy has good efficacy, safety and tolerability.
CONDITIONS
Official Title
Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or non-pregnant female between 18 and 50 years old
- Diagnosed with moderate to severe facial acne vulgaris
- Provided written informed consent
You will not qualify if you...
- Taking photosensitive drugs
- Allergic to any component of the photosensitizer
- Allergies to porphyrins or history of photosensitivity
- Pregnant, lactating, or planning pregnancy within 3 months
- Used oral or topical antibiotics, retinoids, glucocorticoids, peroxybenzoyl, or similar drugs within 1 month
- Sunlight exposure in past month, photoelectric treatment in past 3 months, or facial grinding treatment in past 6 months
- Using vasodilators, beta blockers, anticoagulants, or drugs causing facial capillary dilation
- Having facial rosacea, atopic dermatitis, hormone-dependent dermatitis, or other facial skin diseases
- Abnormal blood/urine tests, liver/kidney function issues, important organ diseases, or hematopoietic system disorders
- Participating in other clinical trials simultaneously
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiyuan Hospital of China Academy of Chinese Medical Sciences Organization
Beijing, China, 100091
Actively Recruiting
Research Team
H
Huiyan Chi, doctor
CONTACT
Y
Yisheng Zhang, doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here